Expression of Human MCM6 and DNA Topo II α in craniopharyngiomas and its correlation with recurrence of the tumor

Journal of Neuro-Oncology

Volumn 83, Issue 2, 2007, Pages 183-189

  Xu, Jianguo ^a,b   Zhang, Sizhong ^a,b   You, Chao ^a   Huang, Siqing ^a   Cai, Bowen ^a   Wang, Xiaojie ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Craniopharyngioma; DNA topoisomerase II lpha; ; Minichromosome maintenance protein 6; Tumor recurrence

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE II ALPHA; MINICHROMOSOME MAINTENANCE PROTEIN; MINICHROMOSOME MAINTENANCE PROTEIN 6; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RELAPSE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOPHARYNGIOMA; EPITHELIUM TUMOR; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PAPILLOMA; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECURRENCE RISK; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CRANIOPHARYNGIOMA; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 34249018016     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-006-9284-0     Document Type: Article

References (43)

1. Bunin GR, Surawicz TS, Witman PA et al (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89:547-551
2. Sung DI (1982) Suprasellar tumors in children: A review of clinical manifestations and managements. Cancer 50:1420-1425
3. McMurry FG, Hardy RW Jr, Dohn DF et al (1977) Long term results in the management of craniopharyngiomas. Neurosurgery 1:238-241
4. Elmaci L, Kurtkaya YO, Ekinci G et al (2002) Metastatic papillary craniopharyngioma: Case study and study of tumor angiogenesis. Neuro-Oncology 4:123-128
5. Ishii K, Sugita K, Kobayashi H et al (2004) Intracranial ectopic recurrence of craniopharyngioma after Ommaya reservoir implantation. Pediatr Neurosurg 40:230-233
6. Nelson GA, Bastian FO, Schlitt M et al (1988) Malignant transformation in craniopharyngioma. Neurosurgery 22:427-429
7. Fuentes S, Metellus P, Dufour H et al (2002) Postoperative intracranial seeding of craniopharygioma. Three case reports and a review of the literature. Neuro-Chirurg 48:345-350
8. Regine WF, Mohiuddin M, Kramer S (1993) Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation. Radiother Oncol 27:13-21
9. Vyramuthu N, Benton TF (1983) The management of craniopharyngioma. Clin Radiol 34:629-632
10. Vidal S, Kovacs K, Lloyd RV et al (2002) Angiogenesis in patients with craniopharyngiomas-correlation with treatment and outcome. Cancer 94:738-745
11. Weiner HL, Wisoff JH, Rosenberg MR et al (1994) Craniopharyngiomas: A clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 35:1001-1011
12. Yasargil MG, Curcic M, Kis M et al (1990) Total removal of craniopharyngiomas: Approaches and long-term results in 144 patients. J Neurosurg 73:3-11
13. Sakai K, Tanaka Y, Hongo K et al (2004) Treatment of craniopharyngiomas in children. Neurol Surg 32:345-353
14. Regina IJ, Bruce HC, Cheryl J et al (2000) Phase II evaluation of interferon-α-2αfor progressive or recurrent craniopharyngiomas. J Neurosurg 92:255-260
15. DeVile CJ, Grant DB, Kendall BE et al (1996) Management of childhood craniopharyngioma: Can the morbidity of radical surgery be predicted?. J Neurog 85:73-81
16. Losa M, Vimercati A, Acerno S et al (2004) Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma. J Neurol Neurosurg Psychiatry 75:889-892
17. Kim SK, Wang KC, Shin SH et al (2001) Radical excision of pediatric craniopharyngioma: Recurrence pattern and prognostic factors. Child's Nerv Syst 17:531-536
18. Ohtani K, Iwanaga R, Nakamura M et al (1999) Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F. Oncogene 18:2299-2309
19. You Z, Masai H (2005) DNA binding and helicase actions of mouse MCM4/6/7 helicase. Nucleic Acids Res 33:3033-3047
20. Kinoshita Y, Johnson EM (2004) Site-specific loading of an MCM protein complex in a DNA replication initiation zone upstream of the c-MYC gene in the HeLa cell cycle. J Biol Chem 279:35879-35889
21. Schwed G, May N, Pechersky Y et al (2002) Drosophila minichromosome maintenance 6 is required for chorion gene amplification and genomic replication. Mol Biol Cell 13:607-620
22. Edwards MC, Tutter AV, Cvetic C et al (2002) MCM2-7 complexes bind chromatin in a distributed pattern surrounding the origin recognition complex in Xenopus egg extracts. J Biol Chem 277:33049-33057
23. Mendez J, Stillman B (2000) Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: Assembly of prereplication complexes in late mitosis. Mol Cell Biol 20:8602-8612
24. Heidebrecht HJ, Buck F, Endl E et al (2001) Ki-Mcm6, a new monoclonal antibody specific to Mcm6: Comparison of the distribution profile of Mcm6 and the Ki-67 antigen. Lab Invest 81:1163-1165
25. Schrader C, Janssen D, Klapper W et al (2005) Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma. Br J Cancer 93:939-945
26. Freeman A, Morris LS, Mills AD et al (1999) Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin Cancer Res 5:2121-2132
27. Raghavan R, Dickey WT, Margraf LR et al (2000) Proliferative activity in craniopharyngiomas: Clinicopathological correlations in adults and children. Surg Neurol 54:241-248
28. Turley H, Comeley M, Houlbrook S et al (1997) The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues. Br J Cancer 75:1340-1346
29. Akimitsu N, Kamura K, Tone S et al (2003) Induction of apoptosis by depletion of DNA topoisomerase II alpha in mammalian cells. Biochem Biophys Res Commun 307:301-307
30. Depowski PL, Rosenthal SI, Brien TP et al (2001) Topoisomerase II alpha expression in breast cancer: Correlation with outcome variable. Mod Pathol 13:542-547
31. Vidal S, Kovacs K, Horvath E et al (2002) Topoisomerase II alpha expression in pituitary adenomas and carcinomas: Relationship to tumor behavior. Mod Pathol 15:1205-1212
32. Ho DM, Hsu CY, Ting LT et al (2003) MIB-1 and DNA topoisomerase II alpha could be helpful for predicting long-term survival of patients with glioblastoma. Am J Clin Pathol 119:715-722
33. Kleihues P, Louis DN, Scheithauer BW et al (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225
34. Hafian H, Venteo L, Sukhanova A et al (2004) Immunohistochemical study of DNA topoisomerase I, DNA topoisomerase II alpha, p53, and Ki-67 in oral preneoplastic lesions and oral squamous cell carcinomas. Hum Pathol 35:745-755
35. Rath-Wolfson L, Hammel I, Kugel V et al (2004) Quantitative microscopy of human DNA topoisomerase II-alpha expression in transitional cell carcinoma of the bladder. Anal Quant Cytol Histol 26:181-186
36. Nishi T, Kuratsu J, Takeshima H et al (1999) Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma. Int J Mol Med 3:157-161
37. Pan J, Qi ST, Deng YJ (2002) Expression of proliferating cell nuclear antigen in craniopharyngioma and tumor recurrence. Di Yi JunYi DaXue XueBao 22:363-365
38. Duo D, Gasverde S, Benech F et al (2003) MIB-1 immunoreactivity in craniopharyngiomas: A clinico-pathological analysis. Clin Neuropathol 22:229-234
39. Helfenstein A, Frahm SQ, Krams M et al (2004) Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: Distinction from enchondroma and identification of progressive tumors. Am J Clin Pathol 122:912-918
40. Garijo JA, Cavadas PC, Vila MM et al (1998) Calcified craniopharyngioma in children. Case report. Neurocirculation 9:57-60
41. Nishimoto A, Matsuhisa T, Kunishio K et al (1995) Craniopharyngioma: early and long term recurrence after partial removal. J Neurol Neurosurg Psychiatry 58:111-112
42. Brandes AA, Vastola F, Basso U (2002) Controversies in the therapy of low-grade glioma: When and how to treat. Expert Rev Anticancer Ther 2:529-536
43. Trinkaus M, Vranic A, Dolenc VV et al (2005) Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas. Int J Biol Markers 20:50-59